Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Darbonne

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 14, 1995
Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophyD Pennica, K L King, K J Shaw, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1990
Endothelial and leukocyte forms of IL-8. Conversion by thrombin and interactions with neutrophilsC A Hébert, F W Luscinskas, J M Kiely, et al.
Nature|June 16, 1994
Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligandF J de Sauvage, P E Hass, S D Spencer, et al.
The Journal of Molecular Diagnostics : JMD|September 5, 2017
High-Throughput and Sensitive Quantification of Circulating Tumor DNA by Microfluidic-Based Multiplex PCR and Next-Generation SequencingYinghui Guan, Oleg Mayba, Thomas Sandmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 21, 2011
Canonical hedgehog signaling augments tumor angiogenesis by induction of VEGF-A in stromal perivascular cellsWeiwei Chen, Tracy Tang, Jeff Eastham-Anderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2014
Potential mechanisms for thrombocytopenia development with trastuzumab emtansine (T-DM1)Hirdesh Uppal, Estelle Doudement, Kaushiki Mahapatra, et al.
Cell Death & Disease|August 12, 2016
Antitherapeutic antibody-mediated hepatotoxicity of recombinant human Apo2L/TRAIL in the cynomolgus monkeyChristina L Zuch de Zafra, Avi Ashkenazi, Walter C Darbonne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2016
A Phase I Dose-Escalation Study Evaluating the Safety Tolerability and Pharmacokinetics of CUDC-427, a Potent, Oral, Monovalent IAP Antagonist, in Patients with Refractory Solid TumorsAnthony W Tolcher, Johanna C Bendell, Kyriakos P Papadopoulos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2011
Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumorsPatricia M LoRusso, Charles M Rudin, Josina C Reddy, et al.
Cancer Chemotherapy and Pharmacology|March 18, 2014
A Phase Ib study evaluating MNRP1685A, a fully human anti-NRP1 monoclonal antibody, in combination with bevacizumab and paclitaxel in patients with advanced solid tumorsAmita Patnaik, Patricia M LoRusso, Wells A Messersmith, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Proceedings of the National Academy of Sciences of the United States of America|February 14, 1995
Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophyD Pennica, K L King, K J Shaw, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1990
Endothelial and leukocyte forms of IL-8. Conversion by thrombin and interactions with neutrophilsC A Hébert, F W Luscinskas, J M Kiely, et al.
Nature|June 16, 1994
Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligandF J de Sauvage, P E Hass, S D Spencer, et al.
The Journal of Molecular Diagnostics : JMD|September 5, 2017
High-Throughput and Sensitive Quantification of Circulating Tumor DNA by Microfluidic-Based Multiplex PCR and Next-Generation SequencingYinghui Guan, Oleg Mayba, Thomas Sandmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 21, 2011
Canonical hedgehog signaling augments tumor angiogenesis by induction of VEGF-A in stromal perivascular cellsWeiwei Chen, Tracy Tang, Jeff Eastham-Anderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2014
Potential mechanisms for thrombocytopenia development with trastuzumab emtansine (T-DM1)Hirdesh Uppal, Estelle Doudement, Kaushiki Mahapatra, et al.
Cell Death & Disease|August 12, 2016
Antitherapeutic antibody-mediated hepatotoxicity of recombinant human Apo2L/TRAIL in the cynomolgus monkeyChristina L Zuch de Zafra, Avi Ashkenazi, Walter C Darbonne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2016
A Phase I Dose-Escalation Study Evaluating the Safety Tolerability and Pharmacokinetics of CUDC-427, a Potent, Oral, Monovalent IAP Antagonist, in Patients with Refractory Solid TumorsAnthony W Tolcher, Johanna C Bendell, Kyriakos P Papadopoulos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2011
Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumorsPatricia M LoRusso, Charles M Rudin, Josina C Reddy, et al.
Cancer Chemotherapy and Pharmacology|March 18, 2014
A Phase Ib study evaluating MNRP1685A, a fully human anti-NRP1 monoclonal antibody, in combination with bevacizumab and paclitaxel in patients with advanced solid tumorsAmita Patnaik, Patricia M LoRusso, Wells A Messersmith, et al.
Pageof 3